Market Tracker

09/30 6:05pm ET

Nektar Therapeutics (NASDAQ:NKTR)

During the Trading Day
12.07 -0.52 / -4.13%
Data as of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.07 +0.0045 / +0.04%
 
Volume: 154.1K

Today’s Trading

Previous close12.59
Today’s open12.53
Day’s range12.06 - 12.63
Volume1,369,200
Average volume (3 months)1,235,334
Market cap$1.6B
Dividend yield--
Data as of 4:14pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+35.25%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co+0.35+0.76%
DYAXDyax Corp-0.39-3.71%
KERXKeryx Biopharmaceuti...+0.05+0.36%
ARIAARIAD Pharmaceutical...-0.38-6.57%
Data as of 4:14pm ET, 09/30/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts